Milk casein-derived tripeptides, VPP and IPP induced NO production in cultured endothelial cells and endothelium-dependent relaxation of isolated aortic rings

Heart and Vessels

Volumn 26, Issue 5, 2011, Pages 549-556

  Hirota, Tatsuhiko ^a   Nonaka, Atsuko ^a   Matsushita, Akiko ^a   Uchida, Naoto ^a   Ohki, Kohji ^a   Asakura, Masanori ^b   Kitakaze, Masafumi ^b  

^a CALPIS Co Ltd   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Endothelium; IPP; Nitric oxide; Vasorelaxation; VPP

Indexed keywords

BRADYKININ B2 RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENZYME INHIBITOR; ISOLEUCYL PROLYL PROLINE; ISOLEUCYL-PROLYL-PROLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLIGOPEPTIDE; POTASSIUM CHANNEL BLOCKING AGENT; VALYL PROLYL PROLINE; VALYL-PROLYL-PROLINE; VASODILATOR AGENT;

ANIMAL; ARTICLE; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MALE; METABOLISM; RAT; THORACIC AORTA; TIME; UMBILICAL VEIN ENDOTHELIAL CELL; VASODILATATION; WISTAR RAT;

ANIMALS; AORTA, THORACIC; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OLIGOPEPTIDES; PEPTIDYL-DIPEPTIDASE A; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 84855726245     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-010-0096-y     Document Type: Article

References (42)

1. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome - a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 23(5):469-480
2. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104(22):2673-2678 [Erratum in: Circulation 108(4):500] (Pubitemid 33108132)
3. Venhoutte PM (1989) Endothelium and control of vascular function. State of the art lecture. Hypertension 13:658-667
4. Lucher TF (1990) Imbalance of endothelium-derived relaxing and contracting factors. A new concept in hypertension? Am J Hypertens 3:317-330
5. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377(6546):239-242
6. Bogle RG, Coade SB, Moncada S, Pearson JD, Mann GE (1991) Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Commun 180(2):926-932
7. Buga GM, Gold ME, Fukuto JM, Ignarro LJ (1991) Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension 17(2):187-193
8. Anderson EA, Mark AL (1989) Flow-mediated and reflex changes in large peripheral artery tone in humans. Circulation 79(1):93-100 (Pubitemid 19043679)
9. Higashi Y, Yoshizumi M (2003) New methods to evaluate endothelial function: method for assessing endothelial function in humans using a strain-gauge plethysmography: nitric oxide-dependent and -independent vasodilatation. J Pharmacol Sci 93(4):399-404 (Pubitemid 38195306)
10. Schiffrin EL, Park JB, Intengan HD, Touyz RM (2000) Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101(14):1653-1659 (Pubitemid 30196624)
11. John S, Schlaich M, Langenfeld M, Weihprecht H, Schmitz G, Weidinger G, Schmieder RE (1998) Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study. Circulation 98(3):211-216 (Pubitemid 28337611)
12. Lonn E, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley W, Teo K, SECURE Investigators (2001) Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103(7):919-925 (Pubitemid 32183795)
13. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342(3):145-153 Erratum in: 2000 May 4;342(18):1376.
14. N Engl J Med Mar 9;342(10):748
15. Stein JH, Keevil JG, Wiebe DA, Aeschlimann S, Folts JD (1999) Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100(10):1050-1055 (Pubitemid 29416230)
16. Chan YH, Lau KK, Yiu KH, Li SW, Chan HT, Tam S, Shu XO, Lau CP, Tse HF (2007) Isoflavone intake in persons at high risk of cardiovascular events: implications for vascular endothelial function and the carotid atherosclerotic burden. Am J Clin Nutr 86(4):938-945 (Pubitemid 47538293)
17. Xu JY, Qin LQ, Wang PY, Li W, Chang C (2008) Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition 24(10):933-940
18. Nakamura Y, Yamamoto N, Sakai K, Takano T (1995) Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J Dairy Sci 78(6):1253-1257
19. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T (1996) A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr 64(5):767-771 (Pubitemid 26398281)
20. Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M, Kajimoto Y, Yamamoto N (2005) Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br J Nutr 94(1):84-91 (Pubitemid 41357814)
21. Hirota T, Ohki K, Kawagishi R, Kajimoto Y, Mizuno S, Nakamura Y, Kitakaze M (2007) Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens Res 30(6):489-496 (Pubitemid 47083118)
22. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37(5):1236-1241 (Pubitemid 34163575)
23. Moncada S, Palmar RMJ, Higgs EA (1990) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Toxicol 30:535-560
24. Asanuma H, Node K, Minamino T, Sanada S, Takashima S, Ueda Y, Sakata Y, Asakura M, Kim J, Ogita H, Tada M, Hori M, Kitakaze M (2003) Celiprolol increases coronary blood flow and reduces severity of myocardial ischemia via nitric oxide release. J Cardiovasc Pharmacol 4(41):499-505 (Pubitemid 36373786)
25. Kitakaze M, Node K, Takashima S, Minamino T, Kuzuya T, Hori M (2000) Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin-converting enzyme in ischemic hearts: role of bradykinin and nitric oxide. Hypertens Res 23(3):253-259 (Pubitemid 30326255)
26. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T (1995) Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78(4):777-783
27. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur J Pharmacol 230(2):215-221
28. Matoba T, Shimokawa H, Kubota H, Morikawa K, Fujiki T, Kunihiro I, Mukai Y, Hirakawa Y, Takeshita A (2002) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 290(3):909-913 (Pubitemid 34687447)
29. Vanhoutte PM, Boulanger CM, Mombouli JV (1995) Endothelium-derived relaxing factors and converting enzyme inhibition. Am J Cardiol 76(15):3E-12E
30. Nakamura T, Mizutani J, Sasaki K, Yamamoto N, Takazawa K (2009) Beneficial potential of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro on central blood pressure and hemodynamic index: a preliminary study. J Med Food 12(6):1-6
31. Yoshizawa M, Maeda S, Miyaki A, Misono M, Choi Y, Shimojo N, Ajisaka R, Tanaka H (2009) Additive beneficial effects of lactotripeptides and aerobic exercise on arterial compliance in postmenopausal women. Am J Physiol Heart Circ Physiol 297:H1899-H1903
32. Yamaguchi N, Kawaguchi K, Yamamoto N (2009) Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis. Eur J Pharmacol 620(1-3):71-77
33. Kaplan HR, Taylor DG, Olson SC, Andrews LK (1989) Quinapril - a preclinical review of the pharmacology, pharmacokinetics, and toxicology. Angiology 40(4 Pt 2):335-350 (Pubitemid 19108868)
34. Comini L, Bachetti T, Cargnoni A, Bastianon D, Gitti GL, Ceconi C, Ferrari R (2007) Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent. Pharmacol Res 56(1):42-48 (Pubitemid 46990929)
35. 2+ channel inhibition in cultured vascular smooth muscle cells. Hypertens Res 28(6):545-552
36. Meluzin J, Vasku A, Kincl V, Panovský R, Srámková T (2009) Association of coronary artery disease, erectile dysfunction, and endothelial nitric oxide synthase polymorphisms. Heart Vessels 24(3):157-163
37. Ari H, Ari S, Erdogan E, Tiryakioǧlu O, Üstündaǧ Y, Huysal K, Koca V, Bozat T (2010) A novel predictor of restenosis and adverse cardiac events: asymmetric dimethylarginine. Heart Vessels 25(1):19-26
38. Ohsawa K, Satsu H, Ohki K, Enjoh M, Takano T, Shimizu M (2008) Producibility and digestibility of antihypertensive beta-casein tripeptides, Val-Pro-Pro and Ile-Pro-Pro, in the gastrointestinal tract: analyses using an in vitro model of mammalian gastrointestinal digestion. J Agric Food Chem 56(3):854-858 (Pubitemid 351300255)
39. Yamamoto N, Akino A, Takano T (1994) Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci Biotechnol Biochem 58(4):776-778
40. Mizuno S, Nishimura S, Matsuura K, Gotou T, Yamamoto N (2004) Release of short and proline-rich antihypertensive peptides from casein hydrolyzate with an Aspergillus oryzae protease. J Dairy Sci 87(10):3183-3188 (Pubitemid 39408453)
41. Meyer J, Bütikofer U, Walther B, Wechsler D, Sieber R (2009) Hot topic: changes in angiotensin-converting enzyme inhibition and concentrations of the tripeptides Val-Pro-Pro and Ile-Pro-Pro during ripening of different Swiss cheese varieties. J Dairy Sci 92(3):826-836
42. van der Pijl PC, Kies AK, Ten Have GAM, Duchateau GSMJE, Deutz NEP (2008) Pharmacokinetics of proline-rich tripeptides in the pig. Peptides 29(12):2196-2202 (Pubitemid 50281507)